"Located on the campus of Wesley Long Hospital, the Cone Health Cancer Center at Wesley Long offers comprehensive, leading-edge services in the area of cancer care. We specialize in the treatment of multiple cancer types including breast cancer, prostate cancer, colon cancer, skin cancer and more."

During the past decade, Cone Health Cancer Center conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 96 clinical trials were completed, i.e. on average, 141.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 52 clinical trials were completed. i.e. 288.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cone Health Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NSABP Foundation Inc" with 9 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cone Health Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Cone Health Cancer Center" are "Breast Cancer" (24 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Colorectal Cancer" (7 trials), "Lung Cancer" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Cone Health Cancer Center" in a lesser frequency.

Most popular intervention types in "Cone Health Cancer Center" are "Drug" (140 trials), "Other" (90 trials), "Biological" (62 trials), "Radiation" (25 trials) and "Procedure" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (30 trials), "Paclitaxel" (23 trials), "Carboplatin" (19 trials) and "Docetaxel" (17 trials). Other intervention names were less common.

The vast majority of trials in "Cone Health Cancer Center" are 115 trials for "All" genders, 53 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Cone Health Cancer Center". undefined are not yet recruiting, 14 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 83 completed trials in Cone Health Cancer Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Cone Health Cancer Center, 10 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".